Market access and HTA – a snapshot of recent developments with Sreeram Ramagopalan: March–August 2024

Read the latest installment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) market access and HTA highlights, a snapshot from his Industry Update article published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The Office of Health Economics (OHE) report on the ongoing evolution of HTA agency methods has some expected findings. The report considered five key topics – discount rates, modifiers, patient involvement, real-world evidence (RWE), and surrogate endpoints. It was expected (and good to hear) that there has been a growing...